Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma

OBJECTIVE: Treatment of differentiated thyroid carcinoma (DTC) includes suppression of TSH with levothyroxine therapy, which may negatively influence bone mineral density (BMD), but the effects are controversial. We aimed to evaluate the relationship between TSH-suppressive therapy and BMD in postme...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Thyroid Res
Glavni autori: de Melo, Thaís Gomes, da Assumpção, Lígia Vera Montalli, Santos, Allan de Oliveira, Zantut-Wittmann, Denise Engelbrecht
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474343/
https://ncbi.nlm.nih.gov/pubmed/26097507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-015-0019-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items